Cited by 98Systemic Lupus Erythematosus ResearchBlood Coagulation and Thrombosis MechanismsVasculitis and related conditions

Update on anti-phospholipid antibodies in SLE: the Hopkins’ Lupus Cohort

Petri, M.·2010·Lupus

Abstract

Anti-phospholipid antibodies are common in patients in the Hopkins’ Lupus Cohort: 47% have anti-cardiolipin, 32.5% anti-β 2 -glycoprotein I and 26% lupus anticoagulant (by dRVVT confirmatory testing). Systemic lupus erythematosus patients with the lupus anticoagulant at baseline have a 50% chance of a deep venous thrombosis/pulmonary embolus in the next 20 years. Anti-phospholipid antibodies differ in their association with thrombosis: the lupus anticoagulant is most strongly associated with arterial and venous thrombosis and is the only anti-phospholipid antibody associated with myocardial infarction. Anti-phospholipid antibodies are not associated with atherosclerosis. Lupus (2010) 19, 419—423.

Integrity signals

Registry

Crossref · 10.1177/0961203309360541

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Petri, M.
Affiliations
Johns Hopkins University (US)
Corresponding author
Petri, M.
Venue
Lupus
Published
2010-03-30
Volume
19
Issue
4
Pages
419-423
ISSN
  • 0961-2033 (ISSN-L)
  • 1477-0962
OpenAlex
W1981177602
Cited by
98
References
14
Citations by year
2026: 1 · 2025: 2 · 2024: 4 · 2022: 3 · 2021: 7 · 2020: 4 · 2019: 5 · 2018: 3 · 2017: 11 · 2016: 5 · 2015: 10 · 2014: 1 · 2013: 15 · 2012: 13
FWCI
9.37
Type
journal article
Language
en
Open access
closed
Locations
  • Lupus (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR 43737)
  • National Center for Research Resources (M01 RR-00052, M01RR000052)
Topics
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Vasculitis and related conditions
Keywords
antiphospholipid antibodies, systemic lupus erythematosus, anticardiolipin antibodies, anti-beta2-glycoprotein I antibodies, lupus anticoagulant, deep vein thrombosis, pulmonary embolism, arterial thrombosis, myocardial infarction, atherosclerosis
MeSH terms
Female, Humans, Longitudinal Studies, Lupus Erythematosus, Systemic, Male, Myocardial Infarction, Pulmonary Embolism, Thrombosis, Time Factors, Cohort Studies, Lupus Coagulation Inhibitor, Antibodies, Antiphospholipid, Antibodies, Anticardiolipin, beta 2-Glycoprotein I

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review